0001213900-21-054992.txt : 20211028
0001213900-21-054992.hdr.sgml : 20211028
20211028112954
ACCESSION NUMBER: 0001213900-21-054992
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211028
DATE AS OF CHANGE: 20211028
EFFECTIVENESS DATE: 20211028
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-418909
FILM NUMBER: 211356136
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
D
1
primary_doc.xml
X0708
D
LIVE
0001728328
InMed Pharmaceuticals Inc.
815 W. HASTINGS STREET
SUITE 310
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
(604) 669-7207
BRITISH COLUMBIA, CANADA
None
None
Corporation
true
Eric
A.
Adams
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Director
Bruce
S.
Colwill
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Alexandra
D.J.
Mancini
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Eric
C.
Hsu
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
Michael
Woudenberg
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Executive Officer
William
J.
Garner
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Catherine
A.
Sazdanoff
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Adam
Cutler
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Andrew
Hull
815 W. Hastings Street
Suite 310
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1B4
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-10-13
false
true
true
Offering made to prior stockholders of BayMedica, Inc., as part of the merger consideration.
0
4305000
4305000
0
Offering made to prior stockholders of BayMedica, Inc., as part of the merger consideration. Total amount sold based on a per share price of $2.10.
true
2
54
0
0
0
false
InMed Pharmaceuticals Inc.
/s/ Bruce S. Colwill
Bruce S. Colwill
Chief Financial Officer
2021-10-28